although
vesicular
stomat
viru
vsv
neurovirul
pathogen
rodent
well
studi
littl
known
vsv
pathogen
nonhuman
primat
address
question
measur
vsv
viremia
shed
neurovirul
macaqu
follow
intranas
inocul
macaqu
shed
minim
recombin
vsv
rvsv
nasal
wash
one
day
postinocul
viremia
detect
follow
intranas
inocul
macaqu
wild
type
wt
vsv
rvsv
two
rvsvhiv
vector
show
evid
spread
cn
tissu
howev
macaqu
inocul
intrathalam
wt
vsv
develop
sever
neurolog
diseas
one
four
macaqu
receiv
rvsv
develop
clinic
histolog
sign
similar
wt
group
remain
three
macaqu
group
macaqu
rvsvhiv
vector
group
show
clinic
sign
diseas
reduc
sever
histopatholog
compar
wt
group
implic
find
rvsv
vaccin
develop
discuss
vesicular
stomat
viru
vsv
nonseg
singlestrand
negativesens
rna
viru
famili
rhabdovirida
recombin
vsv
rvsv
promis
vaccin
vector
simpl
genom
accommod
multipl
foreign
gene
undergo
either
recombin
integr
host
cell
dna
grow
high
titer
mani
differ
cell
type
facilit
vaccin
manufactur
moreov
rvsv
gener
potent
cellular
humor
immun
respons
abundantli
express
foreign
antigen
review
see
rose
whitt
recombin
vsvbase
vector
investig
preclin
vaccin
candid
infecti
diseas
influenza
viru
correspond
author
phone
fax
email
wyethcom
current
address
regeneron
pharmaceut
old
saw
mill
river
road
tarrytown
ny
robert
et
al
respiratori
syncyti
viru
kahn
et
al
measl
viru
schlereth
et
al
schlereth
et
al
papillomaviru
reuter
et
al
robert
et
al
sever
acut
respiratori
syndromecoronaviru
kapadia
et
al
ebola
marburg
virus
jone
et
al
well
human
immunodefici
viru
hiv
egan
et
al
rose
et
al
efficaci
rvsv
vector
demonstr
hiv
vaccin
candid
macaqu
immun
rvsv
express
siv
gag
hiv
env
protein
protect
diseas
follow
challeng
pathogen
sivhiv
hybrid
shiv
egan
et
al
recent
studi
demonstr
enhanc
immunogen
efficaci
macaqu
follow
dnaprim
rvsvboost
vaccin
regimen
egan
et
al
base
promis
result
chose
develop
rvsv
express
hiv
protein
clinic
evalu
prototyp
rvsv
vector
deriv
san
juan
muddsumm
isol
wild
type
wt
indiana
serotyp
vsv
vsv
first
adapt
multipl
passag
cultur
cell
revers
genet
system
allow
rescu
infecti
viru
cdna
lawson
et
al
whelan
et
al
prototyp
vsv
cdna
clone
modifi
allow
foreign
gene
express
schnell
et
al
schnell
et
al
investig
immunogen
efficaci
shiv
challeng
model
separ
rvsv
vector
engin
encod
siv
gag
hiv
env
gene
circumv
high
level
neutral
antibodi
direct
vsv
surfac
glycoprotein
g
rvsv
vector
encod
siv
gag
hiv
env
modifi
exchang
indiana
g
gene
g
gene
vesiculoviru
serotyp
rose
et
al
vector
incorpor
heterolog
glycoprotein
use
boost
macaqu
prime
gindiana
serotyp
vector
egan
et
al
follow
high
dose
shiv
challeng
vaccin
macaqu
abl
control
infect
maintain
low
viral
load
normal
count
remain
free
diseas
five
year
postchalleng
egan
et
al
vsv
natur
pathogen
livestock
caus
diseas
cattl
swine
hors
mark
febril
ill
vesicular
lesion
lip
mouth
nose
teat
hoov
usual
resolv
week
without
fatal
review
letchworth
rodriguez
del
cbarrera
transmiss
occur
direct
contact
infect
anim
thought
abras
scarif
skin
mucos
epithelium
increas
viru
abil
infect
site
letchworth
rodriguez
del
cbarrera
furthermor
evid
bite
insect
may
serv
vector
vsv
brandli
hanson
letchworth
rodriguez
del
cbarrera
tesh
johnson
document
case
human
vsv
infect
rare
tend
occur
agricultur
veterinari
laboratori
worker
area
vsv
infect
endem
natur
host
brandli
hanson
brodi
fischer
peralta
fellow
dimopoullo
calli
ferri
et
al
field
hawkin
hanson
et
al
heini
johnson
vogel
peralta
reif
et
al
webb
et
al
human
infect
typic
subclin
result
mild
flulik
diseas
selflimit
brandli
hanson
fellow
dimopoullo
calli
patterson
mott
jenney
tesh
johnson
enceph
featur
vsv
natur
infect
letchworth
rodriguez
del
cbarrera
vsv
neurotrop
neurovirul
nv
demonstr
rodent
model
bi
et
al
fournier
et
al
fultz
et
al
huneycutt
et
al
miyoshi
harter
hsu
plakhov
et
al
reiss
plakhov
komatsu
sur
allend
doster
van
den
pol
dalton
rose
furthermor
earli
studi
involv
experiment
intracerebr
inocul
rhesu
cynomolgu
macaqu
olitski
cox
syverton
hors
cattl
sheep
frank
applebi
seibold
also
indic
nv
potenti
vsv
recent
chandipura
viru
relat
vesiculoviru
associ
outbreak
enceph
children
india
rao
et
al
although
etiolog
role
chandipura
viru
human
epidem
enceph
question
john
replic
compet
viral
vaccin
histor
subject
nv
test
usual
involv
direct
inocul
viru
central
nervou
system
suscept
nonhuman
primat
nhp
nhp
nv
test
develop
polioviru
nathanson
horn
wood
macadam
measl
viru
sharova
et
al
yamanouchi
et
al
mump
viru
levenbook
et
al
maximova
et
al
rubin
et
al
yellow
fever
viru
levenbook
pelleu
elisberg
marchevski
et
al
case
vaccin
strain
inocul
directli
nhp
brain
compar
refer
control
clinic
paramet
measur
period
day
time
brain
spinal
cord
tissu
analyz
histolog
virusinduc
lesion
nhp
nv
test
yellow
fever
vaccin
involv
score
system
clinic
sign
well
histolog
lesion
cn
tissu
accept
base
comparison
clinic
histolog
score
refer
control
levenbook
pelleu
elisberg
similarli
histolog
lesion
score
system
use
determin
accept
mump
vaccin
lot
follow
direct
inocul
thalamu
nhp
maximova
et
al
develop
rvsv
vaccin
human
use
requir
appropri
attenu
remov
vectorassoci
pathogenesi
previou
studi
mice
indic
low
dose
tissu
cultureadapt
wt
vsv
san
juan
isol
inocul
intranas
caus
weight
loss
paralysi
death
similar
dose
rvsv
caus
weight
loss
mice
similarli
rvsv
vector
encod
influenza
viru
hemagglutinin
gene
caus
transient
weight
loss
follow
intranas
inocul
mice
higher
dose
robert
et
al
rvsv
vector
contain
truncat
g
label
caus
weight
loss
follow
inocul
mice
robert
et
al
indic
abil
decreas
vector
pathogen
attenu
mutat
wellestablish
abil
vsv
caus
nv
rodent
follow
inocul
bi
et
al
huneycutt
et
al
lundh
kristensson
norrbi
olitski
cox
syverton
reiss
plakhov
komatsu
sabin
olitski
sur
allend
doster
weight
loss
observ
mice
follow
inocul
rvsv
vector
robert
et
al
indic
rodent
highli
permiss
vsv
infect
sinc
rhesu
macaqu
inocul
intranas
intramuscularli
high
dose
rvsv
vector
without
advers
clinic
event
egan
et
al
unpublish
observ
decid
assess
rvsvhiv
variant
vectorassoci
pathogen
nhp
three
separ
exploratori
studi
measur
viremia
viral
shed
neuroinvas
follow
inocul
nv
follow
intrathalam
inocul
studi
macaqu
inocul
pfu
viru
highest
dose
previous
test
preclin
nhp
studi
egan
et
al
egan
et
al
neuroinvas
nv
studi
model
stringent
nv
test
use
character
live
mump
viru
yellow
fever
viru
vaccin
prepar
levenbook
et
al
levenbook
pelleu
elisberg
marchevski
et
al
maximova
et
al
rubin
et
al
pilot
studi
perform
measur
viremia
shed
infecti
viru
follow
inocul
three
rhesu
macaqu
pfu
rvsv
figur
blood
serum
collect
predos
along
nasal
wash
saliva
collect
everi
day
first
four
day
follow
inocul
defin
interv
thereaft
see
materi
method
use
standard
plaqu
assay
infecti
viru
observ
nasal
wash
sampl
three
inocul
macaqu
day
tabl
one
macaqu
number
low
level
pfuml
detect
infecti
viru
nasal
wash
day
infecti
viru
detect
nasal
wash
sampl
macaqu
follow
day
two
macaqu
number
highest
titer
viru
nasal
wash
sampl
day
also
shed
low
level
infecti
viru
pfuml
saliva
day
viru
detect
saliva
third
macaqu
number
day
infecti
viru
detect
saliva
macaqu
follow
day
unvaccin
macaqu
serv
neg
control
sampl
time
point
tabl
addit
viral
shed
mucos
surfac
assay
plasma
peripher
blood
mononuclear
cell
pbmc
presenc
infecti
viru
follow
inocul
infecti
viru
detect
plasma
pbmc
macaqu
postinocul
indic
absenc
detect
viremia
vaccin
macaqu
use
vsv
neutral
assay
vsv
specif
serum
antibodi
detect
three
vaccin
macaqu
day
tabl
indic
product
infect
occur
follow
inocul
cynomolgu
macaqu
inocul
day
pfu
vsv
shown
figur
macaqu
clinic
monitor
day
time
subject
euthanasia
necropsi
tissu
harvest
group
mean
clinic
score
macaqu
group
wt
vsv
rvsv
group
indistinguish
score
neg
control
group
assess
neuroinvas
brain
spinal
cord
tissu
harvest
necropsi
analyz
plaqu
assay
realtim
quantit
rtpcr
histopatholog
examin
viru
viral
rna
detect
frontal
cortex
occipit
cortex
olfactori
bulb
csf
nasal
turbin
macaqu
day
furthermor
histopatholog
analysi
reveal
treatment
relat
lesion
chang
present
brain
spinal
cord
macaqu
given
wt
vsv
rvsv
vector
compar
control
macaqu
given
pb
result
indic
none
rvsv
vector
even
wt
vsv
capabl
spread
cn
follow
inocul
demonstr
macaqu
inocul
viru
product
infect
measur
antivsv
neutral
antibodi
tabl
macaqu
wt
vsv
rvsv
rvsv
group
neutral
antibodi
rang
geometr
mean
titer
tabl
macaqu
rvsv
pb
group
detect
neutral
titer
follow
inocul
pfu
viru
four
macaqu
wt
vsv
group
one
four
rvsv
backbon
group
euthan
earli
declin
health
statu
includ
head
tilt
irregular
gait
tremor
ataxia
sign
consist
neurolog
diseas
tabl
onset
sign
gener
occur
day
postinocul
signific
viru
relat
clinic
sign
remain
macaqu
group
tabl
one
pb
control
macaqu
head
tilt
lethargi
bilater
pupil
dilat
day
tabl
onset
sign
occur
earlier
wt
rvsv
group
none
macaqu
control
group
display
similar
sign
conclud
clinic
featur
procedurerel
time
necropsi
sampl
taken
frontal
occipit
cortic
well
csf
assay
infecti
vsv
plaqu
assay
viral
rna
real
time
quantit
rtpcr
five
macaqu
euthan
day
infecti
viru
frontal
cortex
brain
section
proxim
inject
site
viral
titer
within
rang
pfug
tabl
similarli
viral
genom
rna
within
rang
copiesg
detect
frontal
cortex
five
macaqu
none
five
macaqu
euthan
day
infecti
viru
occipit
cortex
distal
inject
site
howev
three
four
macaqu
wt
group
low
level
copiesg
detect
viral
rna
occipit
lobe
addit
low
level
infecti
viru
pfuml
viral
genom
copiesml
detect
csf
one
macaqu
wt
group
tabl
tissu
csf
group
neg
infecti
viru
viral
genom
virus
recov
brain
sampl
macaqu
subject
euthanasia
day
sequenc
across
entir
genom
viru
isol
two
four
macaqu
wt
group
mutat
rel
inoculum
virus
isol
remain
two
wtinocul
macaqu
one
singl
amino
acid
substitut
g
two
substitut
l
tabl
viru
isol
one
rvsv
macaqu
euthan
day
found
contain
ident
sequenc
rel
input
viru
tabl
taken
togeth
result
suggest
clinic
outcom
macaqu
caus
input
virus
rather
select
mutant
increas
nv
potenti
remain
macaqu
rvsv
group
macaqu
rvsv
rvsv
group
infecti
viru
viral
rna
detect
tissu
sampl
collect
necropsi
day
similarli
tissu
pb
group
macaqu
neg
assay
demonstr
product
infect
occur
group
includ
clinic
score
detect
viru
neutral
antibodi
measur
group
macaqu
tabl
macaqu
euthan
day
low
level
neutral
antibodi
geometr
mean
titer
rvsv
rvsv
macaqu
surviv
day
neutral
antibodi
geometr
mean
titer
except
one
macaqu
undetect
neutral
antibodi
titer
rvsv
group
neutral
antibodi
titer
geometr
mean
slide
fix
brain
spinal
cord
tissu
analyz
histolog
chang
tissu
section
observ
lesion
note
accord
rel
size
number
type
eg
inflammatori
necrot
perivascular
periventricular
summar
histolog
find
follow
score
system
use
quantifi
observ
lesion
sever
lesion
minim
moder
mark
sever
tabl
macaqu
inocul
pb
minim
moder
area
malacia
inflamm
local
inject
site
indic
tissu
damag
result
needl
macaqu
pb
averag
clinic
score
length
studi
tabl
display
needl
trackassoci
tissu
damag
tabl
support
notion
clinic
featur
procedur
relat
notabl
lesion
tissu
section
pb
group
figur
tabl
brain
section
macaqu
inocul
wt
vsv
show
moder
sever
necrot
meningoenceph
character
malacia
hemorrhag
choroid
loss
ependym
cell
moder
number
perivascular
cuff
mononuclear
cell
figur
macaqu
inocul
rvsv
lesion
similar
sever
wt
vsv
group
howev
lesion
rvsv
macaqu
character
predomin
cellular
inflammatori
respons
fewer
area
malacia
wt
vsv
inocul
macaqu
figur
macaqu
rvsv
rvsv
group
lesion
primarili
inflammatori
minim
moder
sever
figur
f
tabl
statist
analysi
brain
lesion
score
tabl
reveal
wt
vsv
rvsv
group
significantli
greater
pb
control
goup
p
wherea
rvsv
rvsv
group
score
differ
significantli
pb
control
group
noteworthi
wt
vsv
inocul
macaqu
gener
fewer
less
sever
lesion
spinal
cord
macaqu
rvsv
group
figur
tabl
mean
sever
score
spinal
cord
lesion
wt
vsv
group
figur
minim
mean
score
rvsv
group
figur
mark
macaqu
vector
group
spinal
cord
lesion
less
sever
rvsv
group
mean
sever
score
minim
minim
rvsv
rvsv
respect
figur
f
tabl
observ
may
result
differ
day
necropsi
virus
macaqu
surviv
day
may
opportun
spread
spinal
cord
macaqu
euthan
day
statist
analysi
mean
spinal
cord
lesion
score
tabl
reveal
signific
differ
exist
pb
group
wt
group
two
rvsvhiv
group
p
howev
four
group
significantli
lower
lesion
score
rvsv
group
p
recombin
vsv
candid
hiv
vaccin
vector
demonstr
excel
protect
efficaci
shiv
challeng
studi
macaqu
egan
et
al
howev
rvsv
vector
pathogen
neurotrop
mice
robert
et
al
therefor
design
exploratori
studi
investig
pathogen
rvsv
vector
nhp
prior
advanc
vector
clinic
trial
observ
vectorassoci
pathogen
follow
vaccin
prototyp
rvsv
vector
neuroinvas
studi
neither
wt
vsv
rvsv
vector
show
evid
spread
nasal
tissu
cn
although
viru
detect
sampl
brain
tissu
macaqu
day
possibl
replic
viru
spread
neuron
tissu
proxim
inocul
site
simpli
undetect
day
howev
histolog
analysi
reveal
evid
vsvrelat
neuropatholog
brain
macaqu
inocul
separ
studi
rhesu
macaqu
rvsv
shed
nasal
secret
saliva
low
level
follow
inocul
day
postinocul
tabl
addit
evid
viremia
macaqu
time
point
inocul
therefor
result
well
previou
studi
nhp
egan
et
al
egan
et
al
indic
absenc
vectorassoci
pathogen
neuroinvas
replicationcompet
rvsv
vector
rout
low
level
shed
mucos
surfac
concern
earli
phase
clinic
trial
particularli
neither
vertic
horizont
transmiss
vsv
easili
achiev
either
experiment
natur
infect
brandli
hanson
hanson
reif
et
al
tesh
johnson
follow
inocul
macaqu
wt
vsv
caus
primarili
moder
mark
neuropatholog
measur
clinic
histolog
paramet
result
consist
observ
vsv
neurovirul
macaqu
olitski
cox
syverton
livestock
frank
applebi
seibold
follow
direct
intracerebr
inocul
vector
group
rvsv
similar
wt
group
one
four
anim
group
display
clinic
featur
ident
observ
wt
vsv
group
four
anim
histolog
lesion
score
similar
sever
wt
group
despit
small
number
group
statist
analysi
mean
brain
lesion
score
demonstr
wt
vsv
group
rvsv
vector
group
significantli
increas
lesion
score
respect
pb
control
group
suggest
rvsv
vector
insuffici
attenu
clinic
use
rvsv
rvsv
vector
significantli
attenu
wt
rvsv
backbon
vector
macaqu
model
particularli
clinic
analysi
show
sign
diseas
similar
neg
control
group
tabl
histolog
two
rvsvhiv
vector
caus
lesion
averag
less
sever
inflammatori
natur
wt
rvsv
backbon
vector
group
figur
tabl
mean
brain
lesion
score
rvsvhiv
vector
group
statist
significantli
lower
wt
group
statist
significantli
higher
pb
control
group
presenc
addit
gene
hiv
gag
mutat
like
respons
observ
attenu
virul
histolog
result
tabl
indic
sever
score
wt
vsv
inocul
macaqu
inconsist
brain
section
mean
score
spinal
cord
section
mean
score
result
like
due
fact
wt
inocul
macaqu
euthan
day
may
earli
allow
spread
spinal
cord
detect
replic
viru
occipit
lobe
csf
macaqu
group
tabl
suggest
spread
viru
spinal
cord
occur
via
csf
sinc
spinal
cord
lesion
score
rvsv
rvsv
macaqu
surviv
day
higher
wt
group
tabl
euthan
day
appar
requir
eight
day
viru
caus
spinal
cord
lesion
observ
similar
phenomenon
mice
inocul
intracrani
wt
rvsv
virus
wt
viru
kill
mice
rapidli
brain
lesion
score
lower
rvsv
inocul
mice
surviv
longer
unpublish
result
also
possibl
slight
variat
inocul
procedur
may
result
variat
immedi
distribut
inoculum
macaqu
increas
initi
contamin
csf
viru
consequ
increas
neuropatholog
site
distal
inject
site
histolog
evid
neuropatholog
clearli
reflect
clinic
virolog
paramet
exampl
macaqu
rvsv
rvsv
group
clinic
score
similar
neg
control
group
detect
viru
viral
rna
tissu
day
howev
histolog
analysi
brain
spinal
cord
tissu
indic
product
infect
occur
macaqu
caus
lesion
mostli
minim
moder
mark
tissu
macaqu
tabl
similar
result
observ
three
macaqu
rvsv
group
surviv
day
lack
clinic
sign
detect
viru
coincid
rel
high
lesion
score
brain
spinal
cord
therefor
histolog
analysi
appear
sensit
mean
assess
nv
model
case
nhp
nv
test
yellow
fever
mump
vaccin
levenbook
pelleu
elisberg
maximova
et
al
rubin
et
al
furthermor
viral
load
measur
best
suit
time
point
viral
replic
occur
observ
macaqu
die
euthan
day
base
collect
infect
rtpcr
data
clear
wt
viru
rvsv
backbon
vector
replic
earli
time
point
follow
inocul
detect
replic
ceas
group
day
presum
rvsv
rvsv
virus
also
replic
earli
time
point
serolog
evid
viral
replic
tabl
although
macaqu
inocul
rvsv
rais
detect
neutral
antibodi
viru
like
abl
establish
infect
site
inocul
previous
demonstr
mice
rvsv
vector
gener
low
level
antibodi
singl
inocul
boost
requir
achiev
high
level
antivsv
neutral
antibodi
robert
et
al
subsequ
studi
nhp
nv
model
includ
sampl
cn
tissu
earlier
time
point
accur
measur
viral
replic
within
tissu
regulatori
agenc
histor
requir
nv
test
live
viral
vaccin
case
yellow
fever
mump
vaccin
origin
approv
differ
earli
regulatori
standard
vaccin
strain
must
show
signific
decreas
histopatholog
refer
control
wild
type
strain
signific
increas
histopatholog
refer
control
vaccin
strain
studi
hiv
vaccin
candid
rvsv
rvsv
gener
histopatholog
sever
score
statist
differ
pb
group
statist
lower
wt
group
howev
increas
regulatori
stringenc
lack
establish
safeti
record
rvsv
vector
human
compar
vaccin
measl
mump
polio
yellow
fever
arya
remain
concern
develop
rvsv
vector
vaccin
candid
therefor
proceed
construct
addit
attenu
rvsv
vector
candid
review
clark
et
al
use
approach
gene
rearrang
ball
et
al
flanagan
schoeb
wertz
flanagan
et
al
novella
ball
wertz
wertz
perepelitsa
ball
ablat
express
polypeptid
encod
gene
jayakar
whitt
temperatur
sensit
mutat
flamand
pringl
pringl
gene
delet
truncat
jeetendra
et
al
kahn
et
al
robert
et
al
robison
whitt
addit
concern
regard
util
macaqu
model
rvsv
nv
test
model
statist
signific
differ
histolog
score
rvsv
rvsv
group
tabl
despit
fact
variant
measur
attenu
rvsv
vitro
mice
follow
inocul
robert
et
al
schnell
et
al
addit
wt
vsv
caus
sever
clinic
ill
requir
euthanasia
macaqu
inocul
day
complic
comparison
group
macaqu
surviv
day
nhp
nv
model
vsv
therefor
requir
addit
develop
cost
procur
issu
associ
nhp
also
intend
investig
altern
anim
model
test
rvsv
vectorassoci
pathogen
virus
test
studi
includ
tissu
cultureadapt
wt
vsv
prototyp
attenu
vector
rvsv
rvsv
vector
encod
hiv
gag
protein
attenu
vector
encod
hiv
gag
rvsv
figur
tissu
cultureadapt
san
juan
isol
vsv
indiana
serotyp
wt
vsv
least
attenu
vitro
highli
pathogen
mice
rvsv
deriv
cdna
encod
entir
genom
vsv
lawson
et
al
construct
use
rtpcr
product
combin
genom
vsv
san
juan
muddsumm
isol
result
viru
contain
multipl
nucleotid
sequenc
differ
parent
san
juan
isol
presum
account
vivo
attenu
rvsv
rel
wt
vsv
cdna
serv
backbon
vector
two
rvsvhiv
vector
deriv
prototyp
hiv
vaccin
vector
rvsv
similar
vector
test
previous
shiv
challeng
studi
macaqu
except
vector
encod
gag
protein
rather
siv
gag
final
rvsv
contain
mutant
g
gene
encod
protein
cytoplasm
tail
domain
truncat
amino
acid
singl
amino
acid
mutat
shown
greatli
reduc
vector
pathogen
mice
follow
inocul
robert
et
al
schnell
et
al
sinc
pb
diluent
viru
use
neg
control
inoculum
wild
type
rvsv
rvsv
virus
provid
dr
john
k
rose
yale
univers
new
ct
rvsv
viru
rescu
cdna
pvsv
use
standard
revers
genet
procedur
lawson
et
al
schnell
et
al
cdna
pvsv
gener
pcr
amplif
orf
gag
gene
strain
insert
vsv
vector
backbon
schnell
et
al
via
xho
nhe
restrict
site
fifth
gene
genom
virus
amplifi
babi
hamster
kidney
bhk
cell
multipl
infect
moi
concentr
ultracentrifug
sucros
rpm
beckman
rotor
min
resuspend
phosphat
buffer
salin
pb
rhesu
macaqu
studi
perform
univers
louisiana
lafayettenew
iberia
research
center
new
iberia
la
adher
regul
outlin
usda
anim
welfar
act
cfr
part
condit
specifi
guid
care
use
laboratori
anim
ilar
public
nation
academi
press
clinic
sign
ill
distress
promptli
report
respons
veterinarian
recommend
either
treatment
minor
ailment
injuri
euthanasia
profound
effect
sever
emesi
convuls
limit
avail
macaqu
three
male
rhesu
macaqu
year
old
vaccin
two
uninocul
macaqu
serv
neg
control
figur
follow
light
sedat
ketamin
macaqu
inocul
total
plaqueform
unit
pfu
rvsv
pb
deliv
nostril
total
ml
micropipettor
sampl
collect
follow
saliva
nasal
wash
order
ml
day
serum
ml
predos
day
whole
blood
includ
sodium
heparin
anticoagul
predos
day
nv
neuroinvasivenss
studi
perform
charl
river
laboratori
incpreclin
servic
spark
nv
cynomolgu
macaqu
studi
adher
regul
outlin
usda
anim
welfar
act
cfr
part
condit
specifi
guid
care
use
laboratori
anim
ilar
public
nation
academi
press
clinic
sign
ill
distress
promptli
report
respons
veterinarian
recommend
either
treatment
minor
ailment
injuri
euthanasia
profound
effect
sever
emesi
convuls
cynomolgu
macaqu
year
old
inocul
either
intranas
intrathalam
total
pfu
viru
per
macaqu
figur
group
contain
two
femal
two
male
inocul
macaqu
lightli
sedat
ketamin
macaqu
receiv
total
ml
inoculum
inject
via
syring
nostril
cours
approxim
one
minut
nonantiinflammatori
analges
given
discret
veterinarian
prevent
postinocul
discomfort
inocul
macaqu
anesthet
mixtur
ketamin
valium
macaqu
head
shave
incis
made
skin
approxim
cm
either
side
sagitt
sutur
approxim
cm
coron
sutur
head
macaqu
highspe
gener
twist
drill
use
make
two
cm
hole
skull
correspond
posit
incis
describ
subsequ
ml
viru
control
inoculum
inject
right
left
thalam
region
total
dose
volum
mlmacaqu
use
gaug
inch
needl
depth
approxim
inch
ml
tuberculin
syring
introduc
medialor
direct
inocul
surgic
area
close
subcuticular
sutur
minim
selfinflict
trauma
macaqu
macaqu
observ
recov
anesthesia
return
cage
nonantiinflammatori
analges
given
discret
veterinarian
prevent
postsurg
discomfort
macaqu
monitor
day
challeng
follow
paramet
food
consumpt
bodi
weight
temperatur
serum
chemistri
hematolog
gener
clinic
paramet
latter
score
use
system
base
use
yellow
fever
vaccin
levenbook
pelleu
elisberg
macaqu
examin
twice
daili
possibl
clinic
sign
enceph
assign
numer
score
follow
clinic
sign
enceph
rough
coat
eat
high
pitch
voic
inact
slow
move
shaki
movement
tremor
incoordin
limb
weak
inabl
stand
limb
paralysi
moribund
death
higher
two
daili
individu
macaqu
score
assign
daili
score
mean
daili
clinic
score
macaqu
calcul
averag
individu
macaqu
daili
score
group
mean
daili
score
calcul
studi
day
averag
individu
macaqu
score
group
time
euthanasia
schedul
unschedul
macaqu
exsanguin
deep
anesthesia
induc
ketamin
tissu
fluid
collect
time
euthanasia
quantif
viru
frozen
sampl
occipit
frontal
cortex
thaw
weigh
suspend
pb
supplement
sucros
phosphat
glutam
buffer
sucros
k
hpo
kh
po
glutam
acid
gener
w
v
tissu
suspens
sampl
homogen
use
omni
mixer
es
aerosols
stainless
steel
chamber
omni
intern
tissu
homogen
centrifug
rpm
min
clarifi
supernat
use
immedi
plaqu
assay
rtpcr
describ
cerebr
spinal
fluid
csf
sampl
thaw
use
directli
assay
pbmc
assay
presenc
infecti
vsv
two
method
direct
cocultur
pbmc
bhk
follow
freezethaw
clarif
lysat
brain
spinal
cord
tissu
section
collect
macaqu
follow
gross
necropsi
fix
neutral
buffer
formalin
sampl
taken
five
brain
region
figur
includ
frontal
cortex
occipit
cortex
cerebellum
thalamu
basal
ganglia
three
spinal
cord
region
cervic
thorac
lumbar
tenfold
serial
dilut
tissu
homogen
pbmc
pbmc
lysat
csf
prepar
dulbecco
modifi
eagl
medium
dmem
mediatech
inc
fetal
bovin
serum
fb
aliquot
dilut
place
confluent
bhk
vero
cell
monolay
well
plate
allow
absorb
min
room
temperatur
follow
incub
min
inoculum
remov
well
overlaid
agaros
dmem
fb
plate
incub
overnight
agar
overlay
remov
plate
stain
min
room
temperatur
mlwell
crystal
violet
stain
solut
crystal
violet
methanol
aliquot
tissu
homogen
centrifug
rpm
min
viral
rna
extract
clarifi
supernat
csf
sampl
use
qiaamp
viral
mini
kit
qiagen
inc
equival
volum
buffer
extract
neg
control
aliquot
viral
inoculum
extract
posit
control
use
primer
express
softwar
pe
appli
biosystem
primer
qiagen
probe
ab
appli
biosystem
vsv
n
gene
design
amplifi
fragment
sequenc
forward
primer
follow
correspond
nucleotid
posit
n
open
read
frame
revers
primer
sequenc
follow
correspond
nucleotid
posit
n
open
read
frame
fluorogen
probe
label
end
report
dye
fam
end
quencher
dye
tamra
sequenc
follow
correspond
nucleotid
posit
n
open
read
frame
determin
number
genom
copi
vsv
synthet
rna
oligonucleotid
correspond
entir
amplifi
region
synthes
pagepurifi
trilink
biotechnolog
follow
precipit
centrifug
number
oligonucledotid
copi
per
solut
calcul
use
avogadro
number
molecular
weight
extinct
coeffici
oligonucleotid
serial
dilut
made
synthet
oligonucleotid
use
gener
standard
curv
quantit
rtpcr
assay
develop
twostep
procedur
detect
genom
neg
sens
rna
vsv
initi
reaction
mixtur
revers
transcript
contain
purifi
rna
nm
forward
primer
reagent
revers
transcript
reagent
kit
appli
biosystem
revers
transcriptas
invitrogen
life
technolog
reaction
incub
min
follow
inactiv
step
heat
min
master
mix
buffer
one
step
pcr
master
mix
reagent
kit
appli
biosystem
nm
revers
primer
nm
probe
ad
cdna
reaction
mix
bring
final
volum
amplif
detect
perform
abi
prism
sequenc
detect
system
follow
condit
min
cycl
min
sampl
test
duplic
sera
dilut
pb
volum
serial
twofold
dilut
plate
one
hundr
pfu
viru
rvsv
serumfre
dmem
ad
well
plate
contain
serum
viru
incub
h
approxim
bhk
cell
fb
ad
well
plate
incub
co
day
assay
microscopi
presenc
vsvinduc
cytopatholog
assay
perform
duplic
neutral
titer
assign
highest
dilut
complet
inhibit
vsvinduc
cytopatholog
differ
histopatholog
score
among
group
macaqu
analyz
oneway
analysi
varianc
use
dunnett
multipl
comparison
post
test
instat
version
graphpad
softwar
san
diego
ca
viral
load
assay
macaqu
group
surviv
day
undetect
viral
load
assay
b
tissu
collect
necropsi
csf
collect
immedi
prior
necropsi
c
indic
limit
detect
assay
plaqu
assay
log
pfug
tissu
log
pfuml
csf
rtpcr
assay
log
copiesg
tissu
log
copiesml
csf
virolog
author
manuscript
avail
pmc
march
summari
histopatholog
score
brain
tissu
cynomolgu
macaqu
follow
inocul
brain
section
bg
basal
ganglia
thalamu
c
cerebellum
fc
frontal
cortex
oc
occipit
cortex
see
fig
c
spinal
cord
section
cerv
cervic
thor
thorac
lum
lumbar
see
fig
